Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_assertion type Assertion NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_head.
- NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_assertion description "[The frequencies of promoter methylation of p16, DAPK, CDH1, and TIMP-3 in cervical cancer were 57%, 44.9%, 52.6%, and 9%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_provenance.
- NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_assertion evidence source_evidence_literature NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_provenance.
- NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_assertion SIO_000772 16803511 NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_provenance.
- NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_assertion wasDerivedFrom befree-20140225 NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_provenance.
- NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_assertion wasGeneratedBy ECO_0000203 NP643846.RAGMF1drvLroL1mBSHh9Ky6xiKD3dGFfiMoHpbCO0fkyc130_provenance.